Inhalable formulations for treating pulmonary hypertension and methods of using same

Details for Australian Patent Application No. 2011200464 (hide)

Owner Dey Pharma L.P.

Inventors Chaudry, Imtiaz

Agent Davies Collison Cave

Pub. Number AU-B-2011200464

Parent 2004251014

Filing date 4 February 2011

Wipo publication date 24 February 2011

Acceptance publication date 9 August 2012

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 31/00

A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/401 - Proline

A61K 31/455 - Nicotinic acid, i.e. niacin

A61K 31/554 - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61K 38/55 Medicinal preparations containing peptides - Protease inhibitors

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

Event Publications

17 February 2011 Complete Application Filed

24 February 2011 Application Open to Public Inspection

  Published as AU-B-2011200464

9 August 2012 Application Accepted

  Published as AU-B-2011200464

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011200465-Stable NAD/NADH derivatives

2011200463-Macromolecule-containing sustained release intraocular implants and related methods